68Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Abstract

Current imaging procedures for prostate cancer including positron emission tomography (PET) exhibit considerable limitations and are not always able to meet the diagnostic needs. Recently, a 68Gallium-labeled ligand of the prostate-specific membrane antigen (68Ga-PSMA) has been introduced in PET-imaging of prostate cancer with first promising results. Due to relatively exclusive expression of PSMA in prostatic tissue as well as increased expression in prostate cancer, 68 Ga-PSMA was reported to exhibit a favorable lesion to background ratio. Together with the novel development of combined PET/MRI, the combination of excellent morphological detail, multiparametric functional information, and molecular PET data might lead to a significant improvement in detection of prostate cancer. We present an exemplarily case of primary staging using multiparametric 68Ga-PSMA PET/MR by combining molecular and structural information.

Original languageEnglish
Pages (from-to)1769-1771
Number of pages3
JournalAbdominal Imaging
Volume40
Issue number6
DOIs
StatePublished - 12 Aug 2015

Keywords

  • Ga-PSMA
  • Multiparametric analysis
  • PET/MR
  • Prostate cancer
  • Tumor biology

Fingerprint

Dive into the research topics of '68Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer'. Together they form a unique fingerprint.

Cite this